These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38294838)
1. Impact of Biologics and Small-Molecule Agents on Postoperative Complications in IBD: A Systematic Review. Lee KE; Sizemore JA; Kim G; Shen B; Sands BE Dis Colon Rectum; 2024 Jun; 67(S1):S11-S25. PubMed ID: 38294838 [TBL] [Abstract][Full Text] [Related]
2. Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. Dragoni G; Innocenti T; Amiot A; Castiglione F; Melotti L; Festa S; Savarino EV; Truyens M; Argyriou K; Noviello D; Molnar T; Bouillon V; Bezzio C; Eder P; Fernandes S; Kagramanova A; Armuzzi A; Oliveira R; Viola A; Ribaldone DG; Drygiannakis I; Viganò C; Calella F; Gravina AG; Pugliese D; Chaparro M; Ellul P; Vieujean S; Milla M; Caprioli F; Am J Gastroenterol; 2024 Aug; 119(8):1525-1535. PubMed ID: 38305302 [TBL] [Abstract][Full Text] [Related]
3. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491 [TBL] [Abstract][Full Text] [Related]
4. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD. Moosvi Z; Duong JT; Bechtold ML; Nguyen DL South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791 [TBL] [Abstract][Full Text] [Related]
5. Effect of Inclusion of Oral Antibiotics with Mechanical Bowel Preparation on the Risk of Clostridium Difficile Infection After Colectomy. Al-Mazrou AM; Hyde LZ; Suradkar K; Kiran RP J Gastrointest Surg; 2018 Nov; 22(11):1968-1975. PubMed ID: 29967968 [TBL] [Abstract][Full Text] [Related]
6. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients. Lightner AL; Grass F; Alsughayer AM; Harmsen WS; Petersen M; Loftus EV Dis Colon Rectum; 2020 Jul; 63(7):934-943. PubMed ID: 32149787 [TBL] [Abstract][Full Text] [Related]
7. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418 [TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients. Moosvi Z; Duong J; Bechtold ML; Nguyen DL Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):799-816. PubMed ID: 33079779 [TBL] [Abstract][Full Text] [Related]
9. Perioperative Management of Ulcerative Colitis: A Systematic Review. Lee KE; Faye AS; Vermeire S; Shen B Dis Colon Rectum; 2022 Dec; 65(S1):S5-S19. PubMed ID: 36007165 [TBL] [Abstract][Full Text] [Related]
10. Associations of Specific Postoperative Complications With Outcomes After Elective Colon Resection: A Procedure-Targeted Approach Toward Surgical Quality Improvement. Scarborough JE; Schumacher J; Kent KC; Heise CP; Greenberg CC JAMA Surg; 2017 Feb; 152(2):e164681. PubMed ID: 27926773 [TBL] [Abstract][Full Text] [Related]
11. Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Singh S; Facciorusso A; Dulai PS; Jairath V; Sandborn WJ Clin Gastroenterol Hepatol; 2020 Jan; 18(1):69-81.e3. PubMed ID: 30876964 [TBL] [Abstract][Full Text] [Related]
12. Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles? Lightner AL; McKenna NP; Alsughayer A; Harmsen WS; Taparra K; Parker ME; Raffals LE; Loftus EV Dis Colon Rectum; 2019 Nov; 62(11):1352-1362. PubMed ID: 31567927 [TBL] [Abstract][Full Text] [Related]
13. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Law CC; Bell C; Koh D; Bao Y; Jairath V; Narula N Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013256. PubMed ID: 33098570 [TBL] [Abstract][Full Text] [Related]
14. Effect of Diagnosis on Outcomes in the Setting of Enhanced Recovery Protocols. Ban KA; Berian JR; Liu JB; Ko CY; Feldman LS; Thacker JKM Dis Colon Rectum; 2018 Jul; 61(7):847-853. PubMed ID: 29878952 [TBL] [Abstract][Full Text] [Related]
15. Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis. Bajzát D; Kéri AF; Imrei M; Kói T; Párniczky A; Hegyi P; Kovács K; Váncsa S; Müller KE Inflamm Bowel Dis; 2023 Dec; 29(12):1971-1980. PubMed ID: 36789751 [TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
17. Effects of preoperative anti-tumour necrosis factor alpha infusion timing on postoperative surgical site infection in inflammatory bowel disease: A systematic review and meta-analysis. Qiu Y; Zheng Z; Liu G; Zhao X; He A United European Gastroenterol J; 2019 Nov; 7(9):1198-1214. PubMed ID: 31700633 [TBL] [Abstract][Full Text] [Related]
18. Outcomes After Bowel Resection for Inflammatory Bowel Disease in the Era of Surgical Care Bundles and Enhanced Recovery. D'Andrea AP; Khetan P; Miller R; Sylla P; Divino CM J Gastrointest Surg; 2020 Jan; 24(1):123-131. PubMed ID: 31468328 [TBL] [Abstract][Full Text] [Related]
19. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Borren NZ; Ananthakrishnan AN Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024 [TBL] [Abstract][Full Text] [Related]
20. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]